Infectious Disease Clinics of North America volume 23, issue 1, P99-131 2009 DOI: 10.1016/j.idc.2008.10.008 View full text
|
|
Share
Howard S. Gold, Satish K. Pillai

Abstract: These are interesting times in the treatment of infections caused by Staphylococcus aureus, with shifting epidemiology of antibiotic resistance; changing prevalence of clinical syndromes (probably reflecting changes in virulence of circulating strains); and the recent availability of a variety of new agents with activity against multidrug-resistant gram-positive cocci. The abundance of riches in new drugs for the multidrug-resistant gram-positive space is timely, and these agents show great potential, but as y…

expand abstract